News

The CNTO 95 human antibody was generated using Medarex’s UltiMAb technology. Medarex may receive future milestone payments and royalties should this product candidate progress to commercialization and achieve

Dr LeBel has served as president and COO since June 2008 and has been on Akesis’s board of directors since December 2007. The company has stated that the

Under the terms of the agreement, Replidyne will issue new shares of its common stock to Cardiovascular Systems (CSI) shareholders whereby former CSI shareholders are expected to own

The immediate release formulation of Sanvar, a somatostatin analogue, is used in the treatment of acute esophageal variceal bleeding. It is used prior to endoscopic intervention to control

Hospital procedures range from the use of bone chips, tendons and other tissues in surgeries, organ replacements, and marrow and stem cell transplantations in more advanced therapies. BiologiCare

The practice staffs the level III neonatal intensive care unit at North Oaks Medical Center, which has annual patient volume in excess of 3,500 patient days. Pediatrix has

Under the terms of the agreement, Osiris will commercialize Prochymal and Chondrogen in the US and Canada, and Genzyme will commercialize the treatments in all other countries. Genzyme

Source BioScience has appointed a number of distributors for its Geneservice life science research products in the important East Asian market. EnoGene Biotech has been appointed in China

In his new role, Dr Macdonald will be primarily responsible for developing new commercial opportunities for Sinclair with a particular focus on dermatology products. Dr Macdonald has over